Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04205799
Title Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure (CABOCOL-01)
Acronym CABOCOL-01
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Centre Francois Baclesse
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de cancérologie de l'Ouest Angers France Details
Centre François Baclesse Caen France Details
Centre Oscar LAMBRET Lille France Details
Centre Léon Bérard Lyon France Details
Institut de Cancérologie de Montpellier Montpellier France Details
Institut de cancérologie de l'Ouest Nantes France Details
Institut CURIE Saint-Cloud France Details
Institut Gustave Roussy Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field